Company Overview and News

7
New Strong Buy Stocks for June 20th

18m zacks
CNOOC Limited (CEO - Free Report) : This investment holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 15.7% over the last 60 days.
ENSG PGR CEO

138
5 Value Stocks for Market-Beating Returns

3h zacks
Wall Street has lately been on a choppy ride, with the Dow Jones dropping for the sixth consecutive session on tariff tantrum and erasing of all the gains made this year. The most recent sell-off came after Trump threatened to impose tariffs of up to $400 billion on Chinese goods on top of the $50 billion goods announced on Jun 15. This is the latest escalation in a tit-for-tat tariff dispute between the two world’s largest economies that could spiral into a trade war.
MU MTOR CC CEO HCLP

17
Canadian Solar (CSIQ) to Gain From Strong Pipeline Projects

3h zacks
On Jun 19, 2018, we issued an updated research report on Canadian Solar Inc (CSIQ - Free Report) . The company designs, manufactures and delivers solar products and solar system solutions for on-grid and off-grid use to customers worldwide. Canadian Solar has an impressive earnings surprise history. The company’s earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average being 29.
AZRE SEDG CSIQ CEO

19
Exxon Mobil (XOM) Expedites Liza Phase 1 Development Process

2018-06-13 zacks
Exxon Mobil Corporation (XOM - Free Report) has accelerated the development of the Liza Phase 1 after commencing development drilling offshore Guyana. Development drilling for the first of 17 wells planned for Phase 1 was initiated in May. This facilitated the start of production scheduled for 2020.The Liza prospect, operated by Exxon Mobil, is located about 120 miles (193 kilometers) offshore Guyana in the Stabroek block and spreads across 6.
HES.PRA XOM HES OXY CEO

9
Top Ranked Income Stocks to Buy for June 12th

2018-06-12 zacks
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 12th:
MET TRI PBB PSEC CEO

21
New Strong Buy Stocks for June 8th

2018-06-08 zacks
CNOOC Limited (CEO - Free Report) : This investment holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.
UNP SEDG CEO HCLP

53
5 Oil Stocks to Buy as Geopolitical Tensions Boost Oil Prices

2018-06-08 investorplace
Oil prices trickled down on Jun 6, with the U.S. benchmark crude registering its lowest finish in almost two months. The decline in oil prices can be primarily attributed to a surprise increase in weekly U.S. crude oil inventories. Yet, oil has been one of the best performing sectors over the last few months and is poised for growth.
APC BCEI WRD OXY AEUA CEO

53
Geopolitical Tensions to Boost Oil Prices: 5 Picks

2018-06-07 zacks
Oil prices trickled down on Jun 6, with the U.S. benchmark crude registering its lowest finish in almost two months. The decline in oil prices can be primarily attributed to a surprise increase in weekly U.S. crude oil inventories. Yet, oil has been one of the best performing sectors over the last few months and is poised for growth.
APC WRD BCEI OXY AEUA CEO

69
Oil Majors To Bid On Choice Stakes In Brazil's Offshore

2018-06-07 rigzone
RIO DE JANEIRO, June 7 (Reuters) - Executives from oil majors were set to gather in Rio de Janeiro on Thursday to compete for stakes in Brazil's pre-salt oil play, home to some of the world's most alluring offshore geology, as rising oil prices boost appetite for expensive offshore projects.
FP RDS.B RDS.A XOM BP RDSB RDSA BP.A BP.B BP CVX RYDBF BPAQF RYDAF CEO

69
Oil majors to bid on choice stakes in Brazil's offshore

2018-06-07 reuters
RIO DE JANEIRO (Reuters) - Executives from oil majors were set to gather in Rio de Janeiro on Thursday to compete for stakes in Brazil’s pre-salt oil play, home to some of the world’s most alluring offshore geology, as rising oil prices boost appetite for expensive offshore projects.
FP RDS.B RDS.A XOM BP RDSB RDSA BP.A BP.B BP CVX RYDBF BPAQF RYDAF CEO

31
Phoenix inks deal with CNOOC for LNG project

2018-06-05 bworldonline
PHOENIX Petroleum Philippines, Inc. on Tuesday said it had signed a memorandum of understanding (MoU) with a unit of China National Offshore Oil Corp. (CNOOC) to develop a receiving terminal for imported liquefied natural gas (LNG) in the country.
PNX SMCP1 SMGBY SMGBF SMC2B SMC2A SMC SMC2D PNX3B PNXP SMC2C PNX3A SMC2F SMC2E LNG CEO

80
New Strong Buy Stocks for June 5th

2018-06-05 zacks
CNOOC Limited (CEO - Free Report) : This investment holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 1.4% over the last 60 days.
BRK.A GTES 7018 CME CEO

6
CEO / CNOOC Ltd. FORM 6-K (Current Report of Foreign Issuer)

2018-05-31 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
CEO

6
CEO / CNOOC Ltd. null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P,B P(&]B:@T\/"],:6YE87)I>F5D(#$O3" Q M,#@S-CDO3R Q,#0O12 Y-C,U."].(#,O5" Q,#@P-#,O2"!;(#0Y," Q.3E= M/CX-96YD;V)J#2 @(" @(" @(" @(" @#0HQ,3<@,"!O8FH-/#PO1&5C;V1E M4&%R;7,\/"]#;VQU;6YS(#4O4')E9&EC=&]R(#$R/CXO1FEL=&5R+T9L871E M1&5C;V1E+TE$6SPP-4-!1#$V-$4Y1C,Y1#0X034V-#-%.$,X,T,Q.4%#-CX\ M03=&1C)",T,V1D4U0D0T.3A&139%[email protected],$,S-30^72]);F1E>%LQ,#(@ M,S)=+TEN9F\@,3 Q(# @4B],[email protected]@.
CEO

6
CEO / CNOOC Ltd. null

2018-05-31 sec.gov
中國海洋石油有限公司 CNOOC LIMITED July 6, 2017
CEO

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to CEO / CNOOC Ltd. on message board site Silicon Investor.

Log - Statements by Company CEOs and CFOs Moyco CMP Slurries - CEO Says
Neostem CEO gives a great company update on Stock Radio CEO of OncoSec Medical (ONCS) Exclusive Interview
Great interview from PAAS CEO Corporate Tax Dodgers Spending Big on CEO Pay, Lobbyists
Worldu0027s All-Time Best CEO CEO Turnover
Biotech CEO Resignation/Changes SIFI:TINY FLOAT NEW CEO
CUSIP: 126132109